Hemophilia B

The FDA has released its finalized industry guidance for the development of abuse-deterring opioid drugs.

The FDA has released its finalized industry guidance for the development of abuse-deterring opioid drugs.

The FDA approved the Impella 2.5 System to help stabilize circulation and heart function during high-risk percutaneous coronary intervention procedures.

I am often surprised that any doctors and medical students miss the mark on what FDA stands for.

I am often surprised that any doctors and medical students miss the mark on what FDA stands for.

I am often surprised that any doctors and medical students miss the mark on what FDA stands for.

...

The FDA has announced the approval of a new antifungal drug to treat adults with invasive aspergillosis and invasive mucormycosis.

The FDA has released its recommendations—based on a report by the WHO—for the vaccine components of next year's trivalent and quadrivalent influenza vaccines.

The FDA has approved Zarxio (filgrastim-sndz), the first biosimilar product to be released in the United States, for indications including certain patients with cancer, leukemia, and neutropenia.